Flow Chemistry Continues to Grow
News Jan 14, 2016
Interest in flow chemistry systems has doubled since 2010 according to UK-based flow chemistry engineering specialists Vapourtec (Cambridge, UK) who experienced a further 15% increase in turnover in 2015.
Vapourtec's turnover over the past 5 years has increased by 100% mirroring key industry reports that reveal an ever growing interest and engagement by chemists around the world in continuous process technology.
Vapourtec founder and MD Duncan Guthrie commented: "We've experienced another rapid year of growth and this reflects growing awareness of the benefits and the impressive economies of scale that can be delivered by flow chemistry.
"One recent report revealed 'The global flow chemistry market is projected to reach a market value of US$1,526.3 million in 2020, rising at a compound annual growth rate of 9.5% till 2020.'
"Flow chemistry systems, including those manufactured by ourselves, are playing a big role in bringing down the cost of producing pharmaceutical drugs and industrial chemicals as well as contributing to many major published research breakthroughs.
"Our own systems have been cited in over 180 published, peer-review papers and the pace of those breakthroughs is increasing year on year.
"More and more chemists are experiencing the myriad advantages of a continuous process approach and long may that continue," added Duncan.
Vapourtec design and manufacture flow chemistry systems for a wide variety of sectors including education, pharmaceutical and industry with their technologies used by all of the major pharmaceutical brands.
Exploring Challenges in the Synthesis of Pharmaceutical DrugsNews
This summer, Wendell and Loretta Hess Professor of Chemistry Ram Mohan will travel to India and Hong Kong to deliver a series of post-graduate workshops on advanced concepts in organic synthesis.
His workshop “Advanced Concepts in the Synthesis of Pharmaceutical Drugs” at the Indian Institute of Technology Indore will explore the unique, real-world challenges in the pharmaceutical industry to synthesize drugs that are both commercially viable and eco-friendly.
Modern Alchemists are Making Chemistry GreenerNews
Ancient alchemists tried to turn lead and other common metals into gold and platinum. Modern chemists in Paul Chirik’s lab at Princeton are transforming reactions that have depended on environmentally unfriendly precious metals, finding cheaper and greener alternatives to replace platinum, rhodium and other precious metals in drug production and other reactions.READ MORE
Sartorius Stedim Biotech and Siemens Sign Automation AgreementNews
Siemens becomes a preferred supplier for automation solutions. Product portfolio of Sartorius Stedim Biotech to feature a globally standardized automation platform in the future.READ MORE